Localization of the sites and characterization of the mechanisms by which anti-light chain antibodies neutralize the actions of the botulinum holotoxin.
about
A Single-Domain Llama Antibody Potently Inhibits the Enzymatic Activity of Botulinum Neurotoxin by Binding to the Non-Catalytic α-Exosite Binding RegionEnhancing the Protective Immune Response against BotulismEnhanced neutralization potency of botulinum neurotoxin antibodies using a red blood cell-targeting fusion proteinIsolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque originFolding domains within the ricin toxin A subunit as targets of protective antibodiesIdentification of the factors that govern the ability of therapeutic antibodies to provide postchallenge protection against botulinum toxin: a model for assessing postchallenge efficacy of medical countermeasures against agents of bioterrorism and bMonoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic ActivityInduction of protective neutralizing antibody responses against botulinum neurotoxin serotype C using plasmid carried by PLGA nanoparticlesAnti-nociceptive effect of a conjugate of substance P and light chain of botulinum neurotoxin type ADevelopment of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.P19 embryonal carcinoma cells exhibit high sensitivity to botulinum type C and D/C mosaic neurotoxins.Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system.The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies.A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes.
P2860
Q27659624-A236410C-CD8E-47F4-BAF1-90CB8CC0DB88Q27678122-9139CBB9-FC3B-42AB-9CB0-2B919CB0FB1AQ28742292-0F5A1A1C-9B08-4CFD-9D9A-32AE058DBE28Q31042202-0FA51D32-B757-41CB-A300-03BE2F1BECC7Q34196491-539E8032-5255-4DF9-92A1-0D33A411EB40Q35122868-C946EF8B-0B25-45FA-81A8-A99B6912FA82Q35746555-C6E2E64C-5042-4F2A-954F-D94BFF0ADAB4Q37130982-19C1D1A4-4814-49EE-BA68-D8DD1B39ED74Q37255758-46C33214-099F-4EB8-9C0D-FE6B0A58BB64Q37698936-8B528FE0-9394-4CAB-96AB-348065C8F693Q39324422-385AE50C-7A32-4985-AD5F-FD1DFBCB59CDQ40326402-287A7BF6-7F68-4862-AC74-8F39FED133B7Q45235847-549E7ADC-8C9B-4409-A21D-50CDB654627FQ52679598-E7064219-3CE0-41B2-A57E-56CECFA0DB4D
P2860
Localization of the sites and characterization of the mechanisms by which anti-light chain antibodies neutralize the actions of the botulinum holotoxin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Localization of the sites and ...... ns of the botulinum holotoxin.
@en
Localization of the sites and ...... ns of the botulinum holotoxin.
@nl
type
label
Localization of the sites and ...... ns of the botulinum holotoxin.
@en
Localization of the sites and ...... ns of the botulinum holotoxin.
@nl
prefLabel
Localization of the sites and ...... ns of the botulinum holotoxin.
@en
Localization of the sites and ...... ns of the botulinum holotoxin.
@nl
P2093
P2860
P1433
P1476
Localization of the sites and ...... ns of the botulinum holotoxin.
@en
P2093
Ajay Singh
Denise Ancharski
Fetweh Al-Saleem
Lance L Simpson
Suresh G Joshi
Tsuyoshi Takahashi
Zidoon Nasser
P2860
P304
P356
10.1016/J.VACCINE.2009.02.051
P407
P577
2009-02-24T00:00:00Z